[breadcrumb_custom]

AKBA: Riding the Market Waves of Growth and Decline in 2023

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 32.27%.However, over the last six months, we can see a weaker performance of 8.62%. Over the last 30 days, the price of AKBA has fallen by 5.14%. And in the last five days, it has fallen by -4.08%.

Akebia Therapeutics Inc. experienced a rather steady stock market performance. The highest value in the past year was recorded at $1.84 on 08/01/23 and the lowest value was $0.49 on 04/05/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

52-week price history of AKBA Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Akebia Therapeutics Inc.’s current trading price is -10.86% away from its 52-week high, while its distance from the 52-week low is 234.67%. The stock’s price range during this period has varied between$0.49 and $1.84. The Akebia Therapeutics Inc.’s shares, which operate in the Healthcare, saw a trading volume of around 0.78 million for the day, a figure considerably lower than their average daily volume of 1.6 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Akebia Therapeutics Inc. (AKBA) has experienced a quarterly rise of 50.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 309.00M and boasts a workforce of 205 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1756, with a change in price of +0.3799. Similarly, Akebia Therapeutics Inc. recorded 1,532,756 in trading volume during the last 100 days, posting a change of +30.15%.

AKBA Stock Stochastic Average

Akebia Therapeutics Inc.’s raw stochastic average for the past 50 days is presently 79.26%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 66.02%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 69.18% and 69.60%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts